Novocure Ltd.
Clinical trials sponsored by Novocure Ltd., explained in plain language.
-
Electric field therapy combined with chemo shows promise for tough pancreatic cancer
Disease control CompletedThis pilot study tested a wearable device that delivers low-intensity electric fields (TTFields) together with immunotherapy (atezolizumab) and two chemotherapy drugs (gemcitabine and nab-paclitaxel) in 84 people with metastatic pancreatic cancer who had not received prior treatm…
Phase: PHASE2 • Sponsor: NovoCure Ltd. • Aim: Disease control
Last updated Jun 23, 2026 11:55 UTC
-
Electric field device shows promise in tough pancreatic cancer trial
Disease control CompletedThis phase 3 trial tested a wearable device called Tumor Treating Fields (TTFields) combined with standard chemotherapy for people with locally advanced pancreatic cancer that cannot be removed by surgery. The device sends low-intensity electric fields to the tumor area to disrup…
Phase: PHASE3 • Sponsor: NovoCure Ltd. • Aim: Disease control
Last updated Jun 22, 2026 11:57 UTC
-
Electric field therapy plus standard treatment shows promise for deadly brain cancer
Disease control CompletedThis study tested a device called Optune, which delivers electric fields to the brain, alongside radiation and chemotherapy for people newly diagnosed with glioblastoma, an aggressive brain cancer. About 981 adults took part. The goal was to see if adding Optune to standard treat…
Phase: NA • Sponsor: NovoCure Ltd. • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC